AUS
NZ
UK
CA
USA
IND
Healthcare
Is PolyNovo Limited (ASX:PNV) Delivering Value Through Innovation in Healthcare?
April 04, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,PolyNovo operates in the biomedical field, focused on regenerative medical devices.,Recent attention has highlighted engagement across public and institutional participants.,Governance and strategic alignment are shaped by varied market in...
Genetic Signatures Limited: A Look at Insider Transactions and Ownership
April 03, 2025 05:37 PM AEDT| By Team Kalkine MediaHighlights:,Recent insider purchases reflect confidence in the company’s direction.,Insider ownership accounts for a portion of the company’s total shareholding.,No recent sales have been reported in the latest quarter.,Genetic Signatures Limited (AS...
Race Oncology Advances RC220 Phase 1 Solid Tumour Trial in Australia
April 03, 2025 04:34 PM AEDT| By Team Kalkine MediaHighlights:,Race Oncology Ltd has commenced patient enrolment for the RC220 Phase 1 clinical trial at the Southside Cancer Care Centre in New South Wales.,The study will assess safety, tolerability, and biomarker responses in patients receiving RC220...
Market Movements on the ASX: Key Sector Developments and Company Highlights
April 03, 2025 02:30 PM AEDT| By Team Kalkine MediaHighlights:,Information Technology, Energy, and Real Estate sectors drive shifts on the ASX.,Orthocell (ASX:OCC) awaits US FDA 510(k) clearance for its medical innovation.,Ramelius Resources (ASX:RMS) and Enova Mining (ASX:ENV) report operational mil...
Imugene Advances Phase 1 onCARlytics Trial with IV Dose Escalation for Solid Tumours
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Imugene Ltd (ASX:IMU) has progressed past the initial intravenous dose level in the Phase 1 onCARlytics trial following Cohort Review Committee clearance.,The OASIS study continues evaluating onCARlytics in combination with blinatumomab to...
Is Mesoblast (ASX:MSB) Still on Track After Therapeutic Breakthroughs?
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Mesoblast has advanced its clinical pipeline with new therapy approvals.,Recent share price weakness follows global market fluctuations.,Sector performance and global sentiment may be impacting valuation.,Mesoblast Limited operates within...
Cochlear Limited (ASX:COH) Responds to US Tariff Uncertainty Amid Exemption Clause
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlight:,Cochlear products currently benefit from a US import duty exemption,Awaiting further clarification from US Customs on 10% tariff changes,North America remains a critical export destination for Cochlear,Cochlear Limited (ASX:COH), a global...
CSL Evaluates Broader Implications of U.S. Tariff Measures on Global Operations
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights:,CSL Limited (ASX:CSL) confirms pharmaceutical products currently exempt from new U.S. import tariffs.,Broader implications of country-specific levies on European manufacturing operations under review.,Continued monitoring of evolving U.S....
Fisher & Paykel Healthcare (ASX:FPH) Navigates Tariff Fears Amid Shifting US Trade Policy
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Tariff Impact in FY25 Expected to Be Minimal:,Fisher & Paykel Healthcare does not foresee a material effect on its FY25 net profit after tax from recent U.S. tariff changes.,Increased Exposure in FY26:,Cost pressures and foreign exchange r...
How Might Policy Changes Affect CSL Ltd (ASX:CSL) Global Medical Supply?
April 03, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,CSL Ltd share performance responds to U.S. tariff discussions.,European manufacturing may face strategic shifts if policies tighten.,U.S. plasma operations remain critical to CSL's healthcare focus.,The pharmaceutical and biotechnology ind...
Investors Remain Pessimistic About Neuren Pharmaceuticals Limited's (NEU) Outlook
April 02, 2025 07:31 PM AEDT| By Team Kalkine MediaHighlights:,Neuren Pharmaceuticals reports a price-to-earnings ratio below the broader market.,The company's earnings have shown a decline, influencing its valuation.,Market expectations indicate continued financial challenges in the coming years.,Ne...
Insider Transactions at AdAlta Limited Amid Stock Movement
April 02, 2025 07:31 PM AEDT| By Team Kalkine MediaHighlights:,Insiders at AdAlta Limited experienced a stock price decrease, affecting past transactions.,Stuart Morris made the largest recorded insider acquisition at a specific price per share.,Insider ownership remains significant, aligning closely...
Is Sonic Healthcare's (SHL) Balance Sheet Strong?
April 02, 2025 01:31 PM AEDT| By Team Kalkine MediaIs Sonic Healthcare's (SHL) Balance Sheet Strong?
Nanocap health technology company Cardiex remains stable as 'CONNEQT' integrates with Apple Health.
April 01, 2025 07:16 PM AEDT| By Team Kalkine MediaHighlights:,Cardiex (ASX:CDX) integrates its CONNEQT cardiovascular software with Apple Health for seamless health data management.,The integration enhances user experience by automatically updating health metrics in Apple’s Health Records section.,D...
Neurizon Reports Successful Outcomes for Leading Drug in 3D Brain Model Study
April 01, 2025 06:34 PM AEDT| By Team Kalkine MediaHighlights:,Neurizon Therapeutics and Tessara Therapeutics collaborate on promising neurotherapeutic research.,Lead drug candidate NUZ-001 shows neuroprotective properties and encourages neuroplasticity.,Research results to be presented at the AD/PD...
Race Oncology Gains Ethics Approval for RC220 Phase 1 Trial
April 01, 2025 04:40 PM AEDT| By Team Kalkine MediaHighlights:,Race Oncology has secured human ethics approval for its Phase 1 trial of RC220 in combination with doxorubicin.,The trial will commence at Gosford and Wyong Hospitals in Australia, with patient enrollment expected in April.,Additional eth...
Seaweed Shows Golden Promise: BPH Global’s (ASX:BP8) Latest Assay Results Spark Interest
April 01, 2025 11:44 AM AEDT| By Team Kalkine MediaHighlights,Strong mineral concentrations found in Phase 2 seaweed tests.,Gold levels reach over 123 mg/kg, significantly up from earlier results.,Findings support theory on mineral absorption in polluted waters.,BPH Global (ASX:BP8) has delivered pro...
Pro Medicus (ASX:PME) Announces Major Share Repurchase Initiative
April 01, 2025 12:00 AM AEDT| By Team Kalkine MediaHighlights,Pro Medicus plans a year-long repurchase of up to 10.4 million shares.,Goldman Sachs to oversee the share repurchase program.,The buyback represents about 10% of the shares in the specified class.,Pro Medicus (ASX:PME), a leader in medical...
While many biotech companies are scrounging for funds, Clinuvel faces criticism for having an excess of cash, according to Biocurious.
March 31, 2025 11:00 AM AEDT| By Team Kalkine MediaWhile many biotech companies are scrounging for funds, Clinuvel faces criticism for having an excess of cash, according to Biocurious.
Orthocell Secures FDA Approval for Remplir, Unveiling US Market Potential
March 29, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,FDA grants clearance to Orthocell (OCC) for nerve repair product Remplir.,Entry into the US market poised to boost Orthocell's revenue prospects.,Plans for further expansion into the EU and UK, alongside efforts in Canada and Asia.,Orthoce...
Advertise your brand on Kalkine Media